Future LRMN Events


LRMN & Thermo Fisher Scientific

The November 2014 meeting of the London Regenerative Medicine Network will focus on the scalable manufacturing of cell therapies. Our speakers are three international experts. Each has unique insight into the challenges and potential solutions to deliver cell therapies at the scale required for routine clinal practice.

This meeting is kindly supported by
Thermo Fisher Scientific and is FREE OF CHARGE to attend. Thermo Fisher Scientific unite deep scientific expertise, a collaborative culture and rich resources to deliver the equipment and consumables needed - from cell preparation, through growth, expansion and harvest, to sample storage and transportation. Challenges in the production of cellular therapies are many, including safe navigation in a dynamic regulatory landscape, quality and consistency of processes, and safety and productivity, all in a cost-effective manner.

The meeting will take place on Wednesday 12th November 2014 at 6.00pm in the Medical Sciences 131 A V Hill Lecture Theatre, Medical Sciences and Anatomy Building, University College London - a short walk from Euston Square, Goodge Street and Warren Street Tube Stations and Euston Station.

Registration: 6.00 - 6.30pm
Presentations: 6.30 - 8.25pm
Networking Reception 8.25 - 10.00pm

********

AGENDA:

18.00 - Registration and networking over tea and coffee in the Medical Sciences 131 A V Hill Lecture Theatre (Medical Sciences and Anatomy Building, UCL), while previewing the LRMN Cell Therapy Masterclass with Dr. Kim Warren, Head of Custom Development Services for Cell Therapy at Lonza Walkersville Inc. (Walkersville, MD, US)

18.30 - Welcome - Myriam Jordan (Thermo Fisher Scientific) and Dr. Emily Culme-Seymour (LRMN)

18.35 - The industrialisation of stem cell production - Aidan Courtney, Roslin Cells Ltd. (Edinburgh, UK)

19.05 - Q & A

19.10 - Maturing adherent-cell therapies for commercialisation: Strategies, technology barriers and possible solutions - Dr. Ohad Karnieli, Pluristem Therapeutics Inc. (Haifa, Israel)

19.40 - Q & A

19.45 - Addressing healthcare challenges posed by an aging global population, through innovative regenerative medicine technologies and advances in regulatory strategies - Dr. Gil Van Bokkelen, Athersys Inc. (Cleveland, OH, US)

20.15 - Q & A

20.20 - Closing remarks - Myriam Jordan (Thermo Fisher Scientific) and Dr. Emily Culme-Seymour (LRMN)

20.25 - 22.00 - LRMN Reception - Network whilst enjoying a glass of wine or two in the Garden Room (Wilkins Building, UCL)

********

SPONSORS + PARTNERS

CORPORATE SPONSOR:
Thermo Fisher Scientific

PROMOTIONAL SUPPORT: '
Regenerative Medicine'

*******

PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST REGISTER, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. If you wish to attend, all that is required is to email office@lrmn.com and type 'I will attend' in the subject box. Please only register if you can definitely make the meeting. If you have to cancel later do please let us know.

The LRMN Team very much look forward to welcoming you at 6.00pm on Wednesday 12th November 2014 for an event that will focus on the very latest in scalable manufacturing of cell therapies.


---------------

LRMN & Cell Therapy Catapult

The LRMN is working together again with the Cell Therapy Catapult to hold another event in Winter 2014.

The Cell Therapy Catapult is a centre of excellence in the translation of cell therapies from "bench to bedside". Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth. Based in London at Guy's Hospital, the centre plans to work in collaboration with others to take products through early clinical trials, providing business, clinical, technical, manufacturing and regulatory expertise and to facilitate access to the NHS.

More information on
this event, including a finalised date and the programme will be given in due course, with invitations sent out to the LRMN mailing list as usual.

---------------

LRMN & Miltenyi

The LRMN is working together again with Miltenyi Biotec to hold another event in early Spring 2015.

Miltenyi provide products and services that advance biomedical research and cellular therapy. Regarding stem cell research, currently Mitenyi’s emphasis is on developing tools for the isolation, analysis, and culture of embryonic stem cells, induced pluripotent stem cells, tissue (e.g. neural, cardiac and hepatic) stem cells and cancer stem cells. The latest company developments focus on re-programming, directed differentiation and enrichment of the resulting differentiated cells.

More information on
this event, including a finalised date and the programme will be given in due course, with invitations sent out to the LRMN mailing list as usual.

---------------